Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
McKesson
Novartis
Dow
Chubb
US Army
Moodys
Cipla
Federal Trade Commission

Generated: December 11, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2002-336843

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Gilead Sciences IncGENVOYAcobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarateTABLET;ORAL207561-001Nov 5, 2015RXYesYes► Subscribe► Subscribe► SubscribeYYTREATMENT OF HIV INFECTION
Gilead Sciences IncSTRIBILDcobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarateTABLET;ORAL203100-001Aug 27, 2012RXYesYes► Subscribe► Subscribe► SubscribeYYTREATMENT OF HIV INFECTION
Gilead Sciences IncVITEKTAelvitegravirTABLET;ORAL203093-001Sep 24, 2014DISCNYesNo► Subscribe► Subscribe► SubscribeYYTREATMENT OF HIV INFECTION
Gilead Sciences IncVITEKTAelvitegravirTABLET;ORAL203093-002Sep 24, 2014DISCNYesNo► Subscribe► Subscribe► SubscribeYYTREATMENT OF HIV INFECTION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist